Impact of the COVID-19 lockdown on the severity of newly-diagnosed primary cutaneous melanoma: A retrospective regional study in France

Ann Dermatol Venereol. 2023 Mar;150(1):49-51. doi: 10.1016/j.annder.2022.09.002. Epub 2022 Oct 3.

Authors

L Klepfisch¹, A Carbonnelle-Puscian², M Faisant², J Godeneche², N Provencal², C Lacoste², F Skowron³

Affiliations

¹ Department of Dermatology, Hôpitaux Drome Nord, 607 avenue Geneviève De Gaulle-Anthonioz, 26102 Romans-sur-Isère, France. Electronic address: [email protected].
² Dermatopathology Laboratory, Cypath-Dermapath, 201 Route de Genas, 69100 Villeurbanne, France.
³ Department of Dermatology, Hôpitaux Drome Nord, 607 avenue Geneviève De Gaulle-Anthonioz, 26102 Romans-sur-Isère, France.

No abstract available

Keywords: COVID-19; Epidemiology; Primary cutaneous invasive melanoma; Time to diagnosis.

MeSH terms

COVID-19*
Communicable Disease Control
France
Humans
Melanoma*
Melanoma, Cutaneous Malignant
Retrospective Studies
Skin Neoplasms*